Title:
FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143389
Kind Code:
A1
Abstract:
The present disclosure relates to a fused heterocyclic compound, a preparation method therefor, and a medical application thereof. Specifically, the present disclosure relates to a fused heterocyclic compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and a use thereof as an RIPK1 kinase inhibitor, particularly a use thereof in the preparation of a pharmaceutical for treating a RIPK1 kinase mediation disease or illness.
More Like This:
Inventors:
ZHANG RUI (CN)
LI XIN (CN)
CHEN YIQIAN (CN)
HE FENG (CN)
TAO WEIKANG (CN)
LI XIN (CN)
CHEN YIQIAN (CN)
HE FENG (CN)
TAO WEIKANG (CN)
Application Number:
PCT/CN2023/073194
Publication Date:
August 03, 2023
Filing Date:
January 19, 2023
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
SHANGHAI HENGRUI PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D267/14; A61K31/5513; A61K31/553; A61K31/554; A61P5/50; A61P9/10; A61P25/00; A61P35/00; C07D243/14; C07D291/08; C07D403/06; C07D413/06; C07D413/12; C07D413/14; C07D419/06; C07D471/04; C07D487/04; C07D498/04
Domestic Patent References:
| WO2013006485A1 | 2013-01-10 | |||
| WO2002080895A2 | 2002-10-17 | |||
| WO2017074914A1 | 2017-05-04 | |||
| WO1997030992A1 | 1997-08-28 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: